Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder.
S BavamianN MelliosJasmin LalondeD M FassJ WangS D SheridanJ M MadisonFen ZhouE H RueckertD BarkerR H PerlisM SurS J HaggartyPublished in: Molecular psychiatry (2015)
Bipolar disorder (BD) is a heritable neuropsychiatric disorder with largely unknown pathogenesis. Given their prominent role in brain function and disease, we hypothesized that microRNAs (miRNAs) might be of importance for BD. Here we show that levels of miR-34a, which is predicted to target multiple genes implicated as genetic risk factors for BD, are increased in postmortem cerebellar tissue from BD patients, as well as in BD patient-derived neuronal cultures generated by reprogramming of human fibroblasts into induced neurons or into induced pluripotent stem cells (iPSCs) subsequently differentiated into neurons. Of the predicted miR-34a targets, we validated the BD risk genes ankyrin-3 (ANK3) and voltage-dependent L-type calcium channel subunit beta-3 (CACNB3) as direct miR-34a targets. Using human iPSC-derived neuronal progenitor cells, we further show that enhancement of miR-34a expression impairs neuronal differentiation, expression of synaptic proteins and neuronal morphology, whereas reducing endogenous miR-34a expression enhances dendritic elaboration. Taken together, we propose that miR-34a serves as a critical link between multiple etiological factors for BD and its pathogenesis through the regulation of a molecular network essential for neuronal development and synaptogenesis.
Keyphrases
- long non coding rna
- cell proliferation
- induced pluripotent stem cells
- poor prognosis
- bipolar disorder
- long noncoding rna
- endothelial cells
- genome wide
- cerebral ischemia
- end stage renal disease
- major depressive disorder
- spinal cord
- binding protein
- newly diagnosed
- brain injury
- chronic kidney disease
- multiple sclerosis
- spinal cord injury
- peritoneal dialysis
- transcription factor
- blood brain barrier
- single molecule
- diabetic rats
- drug induced
- pluripotent stem cells
- patient reported